S

Starton Holdings, Inc.

STAFiled

Starton Holdings, Inc. · Nasdaq Capital Market · Research source · S-1/A · 2026-07-13 · Latest filing · S-1/A · 2026-10-28 SEC ↗

Report source
Research source · S-1/A · 2026-07-13
SummaryBASIC RESEARCHReport source · S-1/A

IPO research

Starton Holdings has filed Amendment No. 5 to an S-1 registration statement for a proposed Nasdaq IPO of 5,000,000 common shares under STA.

Full source-backed summary

Starton Holdings is a clinical-stage oncology biotechnology company proposing a 5.0 million-share IPO at an estimated $5.00–$7.00 per share. The filing presents substantial development, financing, going-concern, control and dilution risks; the registration statement remains preliminary and is not yet effective.

Starton Holdings has filed Amendment No. 5 to an S-1 registration statement for a proposed Nasdaq IPO of 5,000,000 common shares under STA.

Ownership and votingAwaiting verified holder data— economic · — voting
Next disclosed checkpointSEC effectiveness, final pricing, Nasdaq listing and offering closing; no effective date or delivery date is supplied.S-1/A · 2026-07-13
Business and development direction

Starton Holdings, Inc.

Current business
Future development
DECISION DRIVERS

Key risks

Risk 1

The company is clinical-stage, has no approved commercial products and has incurred net losses since inception.

Risk 2

The company states that substantial additional capital will be needed even if the offering succeeds.

Next checkSEC effectiveness, final pricing, Nasdaq listing and offering closing; no effective date or delivery date is supplied.
Latest filing2026-10-28
Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Offering qualitySource-linked structured inputs are not yet available. Open filing ↗
BOOKRUNNERS / LEAD UNDERWRITERSUnderwriters named in the prospectus
PRELIMINARY
#InstitutionUnderwriting allocationRatioShares
1Dominari Securities LLC
2Revere Securities LLC
Source and calculation

Names are explicitly identified in source underwriting tables or role clauses. Quantities require the named firm's own table row; missing allocations are not inferred.

Source · S-1/A ↗

IPO CAPITAL QUALITY

Issuer capital
Selling-holder liquidity
Primary shares
Secondary shares
Basis and evidence

S-1/A · 2026-07-13

Starton Holdings has filed Amendment No. 5 to an S-1 registration statement for a proposed Nasdaq IPO of 5,000,000 common shares under STA.

Offering structure

Source and calculation
Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Use of proceedsSource-linked structured inputs are not yet available. Open filing ↗

Dilution and valuation

IPO price—
Basic post-offer≈ 37.7236M
Equity value—

Reported figures remain on their stated basis. Exact compatible price and whole-issuer post-offer inputs are required for calculations.

Dilution and valuation
CalculationSharesValueReference
Post-offer common stock — base/no option37,723,596—
Reported sourcePost-offer · BasesharesBasis and evidence 1 ↗
Pre-offer common stock — as disclosed32,723,596—
Reported sourcePre-offersharesBasis and evidence 2 ↗
Pre-offer Common stock — as disclosed32,362,606—
Reported sourcePre-offersharesBasis and evidence 3 ↗
Basis and evidence ↗
Basis and evidence 1

Prospectus share summary; Shares of Common Stock outstanding after the offering; 37,723,596 shares of common stock (or approximately 38,473,596 if the underwriters’ over-allotment option to purchase additional shares of common stock from us is exercised in full).; selected security: common stock; selected scenario: base/no option; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

Exact input · Post-offer common stock — base/no option: 37,723,596

SEC table 7 row 4 columns 3; share summary; label column 1; source 261803:281649; SHA256 d138faa31ac38db614a9eef45bf2fe259407c16187ef87518137e3f880a9d7a9 ↗

Basis and evidence 2

Prospectus share summary; Shares of Common Stock outstanding before the offering; 32,723,596 shares of common stock as of the date hereof, including shares of common stock issuable in the future, if at all, upon the exchange of an equal number of Exchangeable Shares of Exchangeco (as such terms are defined below).; selected security: common stock; selected scenario: as disclosed; separately stated forfeiture or conversion is not applied to this printed pre-offer count; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

SEC table 7 row 3 columns 3; share summary; label column 1; source 261803:281649; SHA256 d138faa31ac38db614a9eef45bf2fe259407c16187ef87518137e3f880a9d7a9 ↗

Basis and evidence 3

Prospectus share summary; Common stock outstanding prior to this offering as of March 31, 2026; identical printed pre-offer counts across columns 4,8; 32,362,606 32,362,606; selected security: Common stock; selected scenario: as disclosed; separately stated forfeiture or conversion is not applied to this printed pre-offer count; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

SEC table 12 row 7 columns 4,8; share summary; label column 1; source 986330:1068949; SHA256 0d6641e56757327e1c470d14525d97a3b92edc990d1a8acdaad3d65b0f4854ee ↗

Share-count comparison

A compatible whole-issuer pre-offer share count is missing; existing-holder or offered-share allocations cannot substitute for it.

Source ↗
SCENARIO · NOT A FORECAST

IPO valuation scenario simulator

Source inputs required

Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.

Source ↗
Implied equity value—Price × post-offer shares
Post-offer shares—Share count, not tradable float
Existing-holder ownership reduction—Assumes new shares only; secondary sales do not increase shares.
Source and calculation ↗
Security and offer price

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Base post-offer shares

Reported whole-issuer base counts retain explicit option, conversion and surrender assumptions.

Equity value

Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.

Share-count change

A compatible whole-issuer pre-offer share count is missing; existing-holder or offered-share allocations cannot substitute for it.

Alternative scenarios

Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.

Sensitivity

Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.

Source and calculation

The current source URL, accession, hash, proof variants, footnotes, input IDs and executable formulas remain attached. Missing source dates and precision gaps remain explicit.

Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Ownership across stagesSome sourced inputs are available; a compatible set is needed for this view. Open filing ↗
As of
2026-07-13
!The evidence identifies concentrated ownership risk. Current disclosed ownership for executive officers and directors as a group is 8,430,434 shares, or 23.71% before the offering and 20.34% on the stated post-offering basis. Special voting shares and exchangeable shares create additional control complexity.View source ↗
Relationship filters
Show
ownership / voting rights
share structure
Select for details · Starton Holdings, Inc.
Founder / personFund / entityPublic floatShare classEvery relationship is dated and linked to its supporting SEC filing. Percentages marked * are filing-based estimates.

Holdings and voting rights

Holder groups may overlap; these rows are not an additive ownership partition.

Holdings and voting rights
Holder / measureSharesOwnershipVoting rightsReference
Fotios PlakogiannisBeneficial shares3,362,399——
Shares Beneficially OwnedDisclosedEvidence
Litsa PerperidisBeneficial shares2,924,786——
Shares Beneficially OwnedDisclosedEvidence
James KruegerBeneficial shares3,174,000——
Shares Beneficially OwnedDisclosedEvidence
Kiriakos PerperidisBeneficial shares2,014,820——
Shares Beneficially OwnedDisclosedEvidence
Pedro Lichtinger WaismanBeneficial shares5,982,905——
Shares Beneficially OwnedDisclosedEvidence
Eric BaumBeneficial shares480,965——
Shares Beneficially OwnedDisclosedEvidence
Nitin KaushalBeneficial shares463,470——
Shares Beneficially OwnedDisclosedEvidence
Roy F. WaldronBeneficial shares375,162——
Shares Beneficially OwnedDisclosedEvidence
Moses DodoBeneficial shares166,200——
Shares Beneficially OwnedDisclosedEvidence
Scott L. KahnBeneficial shares224,682——
Shares Beneficially OwnedDisclosedEvidence
James C. OliverBeneficial shares737,050——
Shares Beneficially OwnedDisclosedEvidence
All current Executive Officers and Directors as a group (7 persons)Beneficial shares8,430,434——
Shares Beneficially OwnedDisclosedEvidence
Fotios PlakogiannisBeneficial ownership—10.22%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
Fotios PlakogiannisBeneficial ownership—8.7%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
Litsa PerperidisBeneficial ownership—8.94%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
Litsa PerperidisBeneficial ownership—7.6%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
James KruegerBeneficial ownership—9.7%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
James KruegerBeneficial ownership—8.25%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
Kiriakos PerperidisBeneficial ownership—6.06%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
Kiriakos PerperidisBeneficial ownership—5.17%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
Pedro Lichtinger WaismanBeneficial ownership—17.55%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
Pedro Lichtinger WaismanBeneficial ownership—15.02%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
Eric BaumBeneficial ownership—1.46%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
Eric BaumBeneficial ownership—1.24%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
Nitin KaushalBeneficial ownership—1.4%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
Nitin KaushalBeneficial ownership—1.2%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
Roy F. WaldronBeneficial ownership—1.13%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
Roy F. WaldronBeneficial ownership—1%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
James C. OliverBeneficial ownership—2.2%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
James C. OliverBeneficial ownership—1.88%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
All current Executive Officers and Directors as a group (7 persons)Beneficial ownership—23.71%Beneficial—
Percentage of Shares Beneficially Owned; Before OfferingDisclosedEvidence
All current Executive Officers and Directors as a group (7 persons)Beneficial ownership—20.34%Beneficial—
Percentage of Shares Beneficially Owned; After OfferingDisclosedEvidence
Kiriakos PerperidisOwnership as disclosed—>5%Beneficial—
Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding shares of common stock; not an additive ownership partitionDisclosedEvidence
common stockper-share voting rights——1 vote per shareVotes per share
Literal source per-share voting entitlement; common stock; non-cumulative voting; subject to the express source qualifications; full source conditions retained; not a holder voting percentage, ownership amount or controller finding; Source capital-stock section conditions: The following summary gives effect to the Reorganization in November 2025 and our December 9, 2025 1-for-3 reverse stock split.; complete original context retained; Source capital-stock section conditions: source capital/articles apply at the stated offering completion or closing stage; complete original context retainedDisclosedEvidence
Source and calculation ↗
Fotios Plakogiannis · Fotios Plakogiannis — Beneficial shares · 3,362,399

Exact source ownership column: Shares Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares Beneficially Owned; source holder: Fotios Plakogiannis(1)

0001213900-26-077653 · SEC table 27 row 4 columns 3; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:3 ↗

Litsa Perperidis · Litsa Perperidis — Beneficial shares · 2,924,786

Exact source ownership column: Shares Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares Beneficially Owned; source holder: Litsa Perperidis(2)

0001213900-26-077653 · SEC table 27 row 5 columns 3; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:3 ↗

James Krueger · James Krueger — Beneficial shares · 3,174,000

Exact source ownership column: Shares Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares Beneficially Owned; source holder: James Krueger(3)

0001213900-26-077653 · SEC table 27 row 6 columns 3; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:3 ↗

Kiriakos Perperidis · Kiriakos Perperidis — Beneficial shares · 2,014,820

Exact source ownership column: Shares Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares Beneficially Owned; source holder: Kiriakos Perperidis(4)

0001213900-26-077653 · SEC table 27 row 7 columns 3; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:3 ↗

Pedro Lichtinger Waisman · Pedro Lichtinger Waisman — Beneficial shares · 5,982,905

Exact source ownership column: Shares Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares Beneficially Owned; source holder: Pedro Lichtinger Waisman(5)

0001213900-26-077653 · SEC table 27 row 9 columns 3; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:3 ↗

Eric Baum · Eric Baum — Beneficial shares · 480,965

Exact source ownership column: Shares Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares Beneficially Owned; source holder: Eric Baum(6)

0001213900-26-077653 · SEC table 27 row 10 columns 3; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:3 ↗

Nitin Kaushal · Nitin Kaushal — Beneficial shares · 463,470

Exact source ownership column: Shares Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares Beneficially Owned; source holder: Nitin Kaushal(7)

0001213900-26-077653 · SEC table 27 row 11 columns 3; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:3 ↗

Roy F. Waldron · Roy F. Waldron — Beneficial shares · 375,162

Exact source ownership column: Shares Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares Beneficially Owned; source holder: Roy F. Waldron(8)

0001213900-26-077653 · SEC table 27 row 12 columns 3; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:3 ↗

Moses Dodo · Moses Dodo — Beneficial shares · 166,200

Exact source ownership column: Shares Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares Beneficially Owned; source holder: Moses Dodo(9)

0001213900-26-077653 · SEC table 27 row 13 columns 3; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:3 ↗

Scott L. Kahn · Scott L. Kahn — Beneficial shares · 224,682

Exact source ownership column: Shares Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares Beneficially Owned; source holder: Scott L. Kahn(10)

0001213900-26-077653 · SEC table 27 row 14 columns 3; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:3 ↗

James C. Oliver · James C. Oliver — Beneficial shares · 737,050

Exact source ownership column: Shares Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares Beneficially Owned; source holder: James C. Oliver(11)

0001213900-26-077653 · SEC table 27 row 15 columns 3; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:3 ↗

All current Executive Officers and Directors as a group (7 persons) · All current Executive Officers and Directors as a group (7 persons) — Beneficial shares · 8,430,434

Exact source ownership column: Shares Beneficially Owned; holders may overlap; not an additive partition

Raw source column: Shares Beneficially Owned; source holder: All current Executive Officers and Directors as a group (7 persons)

0001213900-26-077653 · SEC table 27 row 16 columns 3; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:3 ↗

Fotios Plakogiannis · Fotios Plakogiannis — Beneficial ownership · 10.22%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: Fotios Plakogiannis(1)

0001213900-26-077653 · SEC table 27 row 4 columns 5,6; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:1 ↗

Fotios Plakogiannis · Fotios Plakogiannis — Beneficial ownership · 8.7%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: Fotios Plakogiannis(1)

0001213900-26-077653 · SEC table 27 row 4 columns 8,9; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:3 ↗

Litsa Perperidis · Litsa Perperidis — Beneficial ownership · 8.94%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: Litsa Perperidis(2)

0001213900-26-077653 · SEC table 27 row 5 columns 5,6; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:1 ↗

Litsa Perperidis · Litsa Perperidis — Beneficial ownership · 7.6%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: Litsa Perperidis(2)

0001213900-26-077653 · SEC table 27 row 5 columns 8,9; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:3 ↗

James Krueger · James Krueger — Beneficial ownership · 9.7%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: James Krueger(3)

0001213900-26-077653 · SEC table 27 row 6 columns 5,6; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:1 ↗

James Krueger · James Krueger — Beneficial ownership · 8.25%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: James Krueger(3)

0001213900-26-077653 · SEC table 27 row 6 columns 8,9; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:3 ↗

Kiriakos Perperidis · Kiriakos Perperidis — Beneficial ownership · 6.06%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: Kiriakos Perperidis(4)

0001213900-26-077653 · SEC table 27 row 7 columns 5,6; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:1 ↗

Kiriakos Perperidis · Kiriakos Perperidis — Beneficial ownership · 5.17%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: Kiriakos Perperidis(4)

0001213900-26-077653 · SEC table 27 row 7 columns 8,9; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:3 ↗

Pedro Lichtinger Waisman · Pedro Lichtinger Waisman — Beneficial ownership · 17.55%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: Pedro Lichtinger Waisman(5)

0001213900-26-077653 · SEC table 27 row 9 columns 5,6; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:1 ↗

Pedro Lichtinger Waisman · Pedro Lichtinger Waisman — Beneficial ownership · 15.02%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: Pedro Lichtinger Waisman(5)

0001213900-26-077653 · SEC table 27 row 9 columns 8,9; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:3 ↗

Eric Baum · Eric Baum — Beneficial ownership · 1.46%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: Eric Baum(6)

0001213900-26-077653 · SEC table 27 row 10 columns 5,6; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:1 ↗

Eric Baum · Eric Baum — Beneficial ownership · 1.24%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: Eric Baum(6)

0001213900-26-077653 · SEC table 27 row 10 columns 8,9; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:3 ↗

Nitin Kaushal · Nitin Kaushal — Beneficial ownership · 1.4%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: Nitin Kaushal(7)

0001213900-26-077653 · SEC table 27 row 11 columns 5,6; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:1 ↗

Nitin Kaushal · Nitin Kaushal — Beneficial ownership · 1.2%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: Nitin Kaushal(7)

0001213900-26-077653 · SEC table 27 row 11 columns 8,9; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:3 ↗

Roy F. Waldron · Roy F. Waldron — Beneficial ownership · 1.13%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: Roy F. Waldron(8)

0001213900-26-077653 · SEC table 27 row 12 columns 5,6; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:1 ↗

Roy F. Waldron · Roy F. Waldron — Beneficial ownership · 1%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: Roy F. Waldron(8)

0001213900-26-077653 · SEC table 27 row 12 columns 8,9; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:3 ↗

James C. Oliver · James C. Oliver — Beneficial ownership · 2.2%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: James C. Oliver(11)

0001213900-26-077653 · SEC table 27 row 15 columns 5,6; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:1 ↗

James C. Oliver · James C. Oliver — Beneficial ownership · 1.88%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: James C. Oliver(11)

0001213900-26-077653 · SEC table 27 row 15 columns 8,9; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:3 ↗

All current Executive Officers and Directors as a group (7 persons) · All current Executive Officers and Directors as a group (7 persons) — Beneficial ownership · 23.71%

Exact source ownership column: Percentage of Shares Beneficially Owned; Before Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; Before Offering; source holder: All current Executive Officers and Directors as a group (7 persons)

0001213900-26-077653 · SEC table 27 row 16 columns 5,6; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:1 ↗

All current Executive Officers and Directors as a group (7 persons) · All current Executive Officers and Directors as a group (7 persons) — Beneficial ownership · 20.34%

Exact source ownership column: Percentage of Shares Beneficially Owned; After Offering; holders may overlap; not an additive partition

Raw source column: Percentage of Shares Beneficially Owned; After Offering; source holder: All current Executive Officers and Directors as a group (7 persons)

0001213900-26-077653 · SEC table 27 row 16 columns 8,9; source 2745524:2829025; SHA256 2195acc9b25f9b79e7679c70fffd92841ffa1c5ab50aecd1bec0737a672c5b75; ownership header cells 1:5,2:3 ↗

Kiriakos Perperidis · Kiriakos Perperidis — Ownership as disclosed · >5%

Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding shares of common stock; not an additive ownership partition

On October 1, 2018, the Company entered into a Consulting Agreement with Kiriakos Capital for Kiriakos Capital Ltd. to provide investor relations and financing consulting services. Kiriakos Perperidis is an owner and officer of Kiriakos Capital Ltd. and beneficially owns more than 5% of our outstanding shares of common stock. The Consulting Agreement provides for a cash consulting fee of $6,000 per month, $96,000 of which has been deferred and remains due and owing as set forth in Deferred Consulting and Service Fees below.

0001213900-26-077653 · SEC ownership paragraph; source 2666873:2667780; SHA256 2bc037b6f50919a6e256a3fb746a567ad3c65087ce55cb117795f19c3426e5e9 ↗

common stock · common stock — per-share voting rights · 1 vote per share

Literal source per-share voting entitlement; common stock; non-cumulative voting; subject to the express source qualifications; full source conditions retained; not a holder voting percentage, ownership amount or controller finding; Source capital-stock section conditions: The following summary gives effect to the Reorganization in November 2025 and our December 9, 2025 1-for-3 reverse stock split.; complete original context retained; Source capital-stock section conditions: source capital/articles apply at the stated offering completion or closing stage; complete original context retained

Holders of our common stock are entitled to one vote for each share for the election of directors and on all other matters submitted to a vote of stockholders, and do not have cumulative voting rights in the election of directors. Whenever corporate action is to be taken by vote of the stockholders, it becomes authorized upon receiving the affirmative vote of a majority of the votes cast by all stockholders entitled to vote on the matter. Subject to preferences that may be granted to any holders of another class of shares, holders of our common stock are entitled to receive ratably only those dividends as may be declared by our board of directors out of funds legally available therefor, as well as any distributions to our stockholders. In the event of our liquidation, dissolution or winding up, holders of our common stock are entitled to share ratably in all of our assets remaining after we pay our liabilities and distribute the liquidation preference of any class of our shares that has a liquidation preference over our common stock. Source context: The following summary describes our capital stock and the material provisions of our certificate of incorporation, our bylaws and of the Delaware General Corporation Law. The following summary gives effect to the Reorganization in November 2025 and our December 9, 2025 1-for-3 reverse stock split. Because the following is only a summary, it does not contain all of the information that may be important to you. For a complete description, you should refer to our certificate of incorporation, bylaws and investors’ rights agreements, copies of which will be filed as exhibits to the registration statement of which this prospectus is part. Source context: Upon the closing of this offering, our authorized capital stock, will consist of 200,000,000 shares of our common stock, par value $0.001 per share, 45,000,000 shares of special voting stock, par value $0.001 per share, and 5,000,000 shares of preferred stock, par value $0.001 per share. Prior to the completion of this offering, we expect to have approximately 400 holders of record of our common stock. The following description summarizes the terms of our capital stock. Because it is only a summary, it does not contain all the information that may be important to you. For a complete description you should refer to our form of certificate of incorporation and our form of bylaws, as in effect immediately following the closing of this offering, copies of which will be filed as exhibits to the registration statement of which this prospectus is a part.

0001213900-26-077653 · SEC ownership excerpt; source 2844967:2846372; SHA256 88c7c85280d19180ea93a912cd105d2c1c01b8df143ad6aa97fa54f9828c2f54; context source 2841379:2842811; SHA256 d0e60730337e50189ee0e24aef8367433bec27e594f7d937a2b2a8c94076bbb9; context source 2843243:2844530; SHA256 c2ca0b32831ce6418a5d493828992f10ff0612a1108b17513a9acd6f8c8dfaf5 ↗

Economic ownership

A chart needs complete, non-overlapping economic interests on one date and share basis. The disclosed holder figures remain in the table.

Share supply

Source lock-up conditions

Literal day restriction; after date of this prospectus; full conditions and exceptions remain in the source paragraph

Source lock-up conditions
MeasureReported value
Our directors, executive officers and holders of more than 5.0% of our outstanding shares of common stock or securities convertible into or exchangeable for shares of our common stockAfter date of this prospectus · Source conditions apply180 days
our directors, officers and holders of more than 5.0% of our outstanding common stockAfter date of this prospectus · Source conditions apply180 days
We, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stockAfter date of this prospectus · Source conditions apply180 days
We, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stockAfter date of this prospectus · Source conditions apply180 days
Source and calculation
Our directors, executive officers and holders of more than 5.0% of our outstanding shares of common stock or securities convertible into or exchangeable for shares of our common stock

Our directors, executive officers and holders of more than 5.0% of our outstanding shares of common stock or securities convertible into or exchangeable for shares of our common stock have entered into lock-up agreements with the Representative pursuant to which they may not, with limited exceptions, for a period of 180 days from the date of this prospectus, offer, sell or otherwise transfer or dispose of any of our securities, without the prior written consent of the Representative. Sales of these shares, or perceptions that they will be sold, could cause the trading price of our common stock to decline. After the lock-up agreements expire, up to an additional approximately 18.2 million shares of common stock will be eligible for sale in the public market, which will be held by directors, executive officers and

SEC lock-up paragraph; source 832266:833599; SHA256 b5ffb148bd648975192ae1b07196530dbdf24c9a522a2c6eaf6b3176a0a8677d ↗
our directors, officers and holders of more than 5.0% of our outstanding common stock

We, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock have agreed with the Representative (as defined below), subject to certain exceptions, not to sell, transfer or dispose of, directly or indirectly, any of our shares of common stock or securities convertible into or exercisable or exchangeable for our common stock for a period of 180 days after the date of this prospectus. See “Underwriting” for more information.

SEC table 7 row 8; source 261803:281649; SHA256 d138faa31ac38db614a9eef45bf2fe259407c16187ef87518137e3f880a9d7a9 ↗
We, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock

We, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock have agreed with the Representative (as defined below), subject to certain exceptions, not to sell, transfer or dispose of, directly or indirectly, any of our shares of common stock or securities convertible into or exercisable or exchangeable for our common stock for a period of 180 days after the date of this prospectus. See “Underwriting” for more information.

SEC lock-up paragraph; source 280765:281616; SHA256 bc00fc0e1a4bf08760f5b6e7a177eac41fa2f2b46bf85747bfc654653f2e309b ↗
We, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock

We, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock have agreed with the Representative (as defined below), subject to certain exceptions, not to sell, transfer or dispose of, directly or indirectly, any of our shares of common stock or securities convertible into or exercisable or exchangeable for our common stock for a period of 180 days after the date of this prospectus. See “Underwriting” for more information.

SEC table 7 row 8; source 261803:281649; SHA256 d138faa31ac38db614a9eef45bf2fe259407c16187ef87518137e3f880a9d7a9 ↗

Source statements

Express180-day FINRA5110lock-up applies to underwriters warrants and underlying securities only. Three years describes warrant expiry/registration rights, not this restriction or an issuer lock-up. Source conditions retained; no calendar release inferred.

Source statements
MeasureReported value
Underwriters’ warrants and underlying securities — Restriction (days)180 days
Source and calculation
Underwriters’ warrants and underlying securities — Restriction (days)

We have agreed to issue to the underwriters (or their permitted designees) warrants to purchase up to a total of 287,500 shares of common stock (5.0% of the shares of common stock issued in this offering, including shares of common stock sold upon exercise of the over-allotment option, if any). The warrants will be non-exercisable for six (6) months after the commencement of sales of the common stock in this offering and will expire three (3) years after the commencement of sales, which is also the effective date of the registration statement of which this prospectus is a part, which period is in compliance with applicable FINRA rules. The warrants are exercisable at a per share price equal to 125% of the initial public offering price per share of common stock issued in this offering. The warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(e)(l)(A) of FINRA. The underwriters (or permitted assignees under Rule 5110(e)(2)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period commencing 180 days from the commencement of sales of the common stock in this offering. The underwriters’ warrants will have one demand and unlimited piggyback registration rights at our expense for a period of three years from the commencement of sales of the offering in compliance with applicable FINRA rules (provided such registration rights will not apply to any universal shelf registration statement). We will bear all fees and expenses attendant to registering the securities issuable on exercise of the warrants. The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary cash dividend or our recapitalization, reorganization, merger, or consolidation. However, the warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price below the warrant exercise price.

SEC lock-up paragraph; source 2968074:2970885; SHA256 e8d53454648f41aee0c03a4461628cdd4d33e270cd28a78e402a4daedf54ff90 ↗

Conditional lock-up timeline

Conditional lock-up timeline

Eligibility is not a sale. Release conditions, holder groups and exceptions remain separate.

date of this prospectus

  1. Our directors, executive officers and holders of more than 5.0% of our outstanding shares of common stock or securities convertible into or exchangeable for shares of our common stockOur directors, executive officers and holders of more than 5.0% of our outstanding shares of common stock or securities convertible into or exchangeable for shares of our common stock have entered into lock-up agreements with the Representative pursuant to which they may not, with limited exceptions, for a period of 180 days from the date of this prospectus, offer, sell or otherwise transfer or dispose of any of our securities, without the prior written consent of the Representative. Sales of these shares, or perceptions that they will be sold, could cause the trading price of our common stock to decline. After the lock-up agreements expire, up to an additional approximately 18.2 million shares of common stock will be eligible for sale in the public market, which will be held by directors, executive officers and
  2. our directors, officers and holders of more than 5.0% of our outstanding common stockWe, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock have agreed with the Representative (as defined below), subject to certain exceptions, not to sell, transfer or dispose of, directly or indirectly, any of our shares of common stock or securities convertible into or exercisable or exchangeable for our common stock for a period of 180 days after the date of this prospectus. See “Underwriting” for more information.
  3. We, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stockWe, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock have agreed with the Representative (as defined below), subject to certain exceptions, not to sell, transfer or dispose of, directly or indirectly, any of our shares of common stock or securities convertible into or exercisable or exchangeable for our common stock for a period of 180 days after the date of this prospectus. See “Underwriting” for more information.
  4. We, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stockWe, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock have agreed with the Representative (as defined below), subject to certain exceptions, not to sell, transfer or dispose of, directly or indirectly, any of our shares of common stock or securities convertible into or exercisable or exchangeable for our common stock for a period of 180 days after the date of this prospectus. See “Underwriting” for more information.
Holder / event
Holder / eventTerm / dateConditions
Our directors, executive officers and holders of more than 5.0% of our outstanding shares of common stock or securities convertible into or exchangeable for shares of our common stock180 daysOur directors, executive officers and holders of more than 5.0% of our outstanding shares of common stock or securities convertible into or exchangeable for shares of our common stock have entered into lock-up agreements with the Representative pursuant to which they may not, with limited exceptions, for a period of 180 days from the date of this prospectus, offer, sell or otherwise transfer or dispose of any of our securities, without the prior written consent of the Representative. Sales of these shares, or perceptions that they will be sold, could cause the trading price of our common stock to decline. After the lock-up agreements expire, up to an additional approximately 18.2 million shares of common stock will be eligible for sale in the public market, which will be held by directors, executive officers and
our directors, officers and holders of more than 5.0% of our outstanding common stock180 daysWe, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock have agreed with the Representative (as defined below), subject to certain exceptions, not to sell, transfer or dispose of, directly or indirectly, any of our shares of common stock or securities convertible into or exercisable or exchangeable for our common stock for a period of 180 days after the date of this prospectus. See “Underwriting” for more information.
We, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock180 daysWe, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock have agreed with the Representative (as defined below), subject to certain exceptions, not to sell, transfer or dispose of, directly or indirectly, any of our shares of common stock or securities convertible into or exercisable or exchangeable for our common stock for a period of 180 days after the date of this prospectus. See “Underwriting” for more information.
We, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock180 daysWe, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock have agreed with the Representative (as defined below), subject to certain exceptions, not to sell, transfer or dispose of, directly or indirectly, any of our shares of common stock or securities convertible into or exercisable or exchangeable for our common stock for a period of 180 days after the date of this prospectus. See “Underwriting” for more information.

Milestones and unconfirmed releases

Holder / event
Holder / eventTerm / dateConditions
Underwriters’ warrants and underlying securities — Restriction (days)180 daysWe have agreed to issue to the underwriters (or their permitted designees) warrants to purchase up to a total of 287,500 shares of common stock (5.0% of the shares of common stock issued in this offering, including shares of common stock sold upon exercise of the over-allotment option, if any). The warrants will be non-exercisable for six (6) months after the commencement of sales of the common stock in this offering and will expire three (3) years after the commencement of sales, which is also the effective date of the registration statement of which this prospectus is a part, which period is in compliance with applicable FINRA rules. The warrants are exercisable at a per share price equal to 125% of the initial public offering price per share of common stock issued in this offering. The warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(e)(l)(A) of FINRA. The underwriters (or permitted assignees under Rule 5110(e)(2)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period commencing 180 days from the commencement of sales of the common stock in this offering. The underwriters’ warrants will have one demand and unlimited piggyback registration rights at our expense for a period of three years from the commencement of sales of the offering in compliance with applicable FINRA rules (provided such registration rights will not apply to any universal shelf registration statement). We will bear all fees and expenses attendant to registering the securities issuable on exercise of the warrants. The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary cash dividend or our recapitalization, reorganization, merger, or consolidation. However, the warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price below the warrant exercise price.
Basis and evidence
Our directors, executive officers and holders of more than 5.0% of our outstanding shares of common stock or securities convertible into or exchangeable for shares of our common stock

Our directors, executive officers and holders of more than 5.0% of our outstanding shares of common stock or securities convertible into or exchangeable for shares of our common stock have entered into lock-up agreements with the Representative pursuant to which they may not, with limited exceptions, for a period of 180 days from the date of this prospectus, offer, sell or otherwise transfer or dispose of any of our securities, without the prior written consent of the Representative. Sales of these shares, or perceptions that they will be sold, could cause the trading price of our common stock to decline. After the lock-up agreements expire, up to an additional approximately 18.2 million shares of common stock will be eligible for sale in the public market, which will be held by directors, executive officers and

SEC lock-up paragraph; source 832266:833599; SHA256 b5ffb148bd648975192ae1b07196530dbdf24c9a522a2c6eaf6b3176a0a8677d ↗
our directors, officers and holders of more than 5.0% of our outstanding common stock

We, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock have agreed with the Representative (as defined below), subject to certain exceptions, not to sell, transfer or dispose of, directly or indirectly, any of our shares of common stock or securities convertible into or exercisable or exchangeable for our common stock for a period of 180 days after the date of this prospectus. See “Underwriting” for more information.

SEC table 7 row 8; source 261803:281649; SHA256 d138faa31ac38db614a9eef45bf2fe259407c16187ef87518137e3f880a9d7a9 ↗
We, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock

We, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock have agreed with the Representative (as defined below), subject to certain exceptions, not to sell, transfer or dispose of, directly or indirectly, any of our shares of common stock or securities convertible into or exercisable or exchangeable for our common stock for a period of 180 days after the date of this prospectus. See “Underwriting” for more information.

SEC lock-up paragraph; source 280765:281616; SHA256 bc00fc0e1a4bf08760f5b6e7a177eac41fa2f2b46bf85747bfc654653f2e309b ↗
We, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock

We, our successors, all of our directors, officers and holders of more than 5.0% of our outstanding common stock have agreed with the Representative (as defined below), subject to certain exceptions, not to sell, transfer or dispose of, directly or indirectly, any of our shares of common stock or securities convertible into or exercisable or exchangeable for our common stock for a period of 180 days after the date of this prospectus. See “Underwriting” for more information.

SEC table 7 row 8; source 261803:281649; SHA256 d138faa31ac38db614a9eef45bf2fe259407c16187ef87518137e3f880a9d7a9 ↗
Underwriters’ warrants and underlying securities — Restriction (days)

We have agreed to issue to the underwriters (or their permitted designees) warrants to purchase up to a total of 287,500 shares of common stock (5.0% of the shares of common stock issued in this offering, including shares of common stock sold upon exercise of the over-allotment option, if any). The warrants will be non-exercisable for six (6) months after the commencement of sales of the common stock in this offering and will expire three (3) years after the commencement of sales, which is also the effective date of the registration statement of which this prospectus is a part, which period is in compliance with applicable FINRA rules. The warrants are exercisable at a per share price equal to 125% of the initial public offering price per share of common stock issued in this offering. The warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(e)(l)(A) of FINRA. The underwriters (or permitted assignees under Rule 5110(e)(2)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period commencing 180 days from the commencement of sales of the common stock in this offering. The underwriters’ warrants will have one demand and unlimited piggyback registration rights at our expense for a period of three years from the commencement of sales of the offering in compliance with applicable FINRA rules (provided such registration rights will not apply to any universal shelf registration statement). We will bear all fees and expenses attendant to registering the securities issuable on exercise of the warrants. The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary cash dividend or our recapitalization, reorganization, merger, or consolidation. However, the warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price below the warrant exercise price.

SEC lock-up paragraph; source 2968074:2970885; SHA256 e8d53454648f41aee0c03a4461628cdd4d33e270cd28a78e402a4daedf54ff90 ↗

Financial quality

Bars compare absolute amounts within each measure. Each measure has its own scale.

Net income / (loss)

$ · Annual values as reported · Consolidated
FY2025($9,477,969)
FY2026($15,396,839)

Operating cash flow

$ · Annual values as reported · Consolidated
FY2025($8,253,796)
FY2026($8,576,956)
Financial quality
CalculationFY2025FY2026
Net income / (loss)Consolidated($9,477,969)($15,396,839)
Operating cash flowConsolidated($8,253,796)($8,576,956)
Financial quality
CalculationReported value
Current assets2026-03-31 · Consolidated$1,802,461
Current assets2025-03-31 · Consolidated$1,457,929
Total assets2026-03-31 · Consolidated$7,675,191
Total assets2025-03-31 · Consolidated$7,045,775
Current liabilities2026-03-31 · Consolidated$8,178,223
Current liabilities2025-03-31 · Consolidated$7,326,226
Total liabilities2026-03-31 · Consolidated$10,736,107
Total liabilities2025-03-31 · Consolidated$8,506,121
Total equity / (deficit)2026-03-31 · Consolidated($3,060,916)
Total equity / (deficit)2025-03-31 · Consolidated($1,460,346)
General and administrative expensesFY2026 · Consolidated$7,724,398
General and administrative expensesFY2025 · Consolidated$6,683,621
Basis and evidence
Total current assets
March 31, 2026; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2026-03-31
Total current assets
March 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-03-31
Total assets
March 31, 2026; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2026-03-31
Total assets
March 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-03-31
Total current liabilities
March 31, 2026; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2026-03-31
Total current liabilities
March 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-03-31
Total liabilities
March 31, 2026; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2026-03-31
Total liabilities
March 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-03-31
Total stockholders’ deficit
March 31, 2026; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2026-03-31
Total stockholders’ deficit
March 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-03-31
General and administrative
FY2026; consolidated; currency symbol as printed ($); ISO currency not assigned; year ended 2026-03-31
General and administrative
FY2025; consolidated; currency symbol as printed ($); ISO currency not assigned; year ended 2025-03-31
Net loss
FY2026; consolidated; currency symbol as printed ($); ISO currency not assigned; year ended 2026-03-31
Net loss
FY2025; consolidated; currency symbol as printed ($); ISO currency not assigned; year ended 2025-03-31
Net cash used in operating activities
FY2026; consolidated; currency symbol as printed ($); ISO currency not assigned; year ended 2026-03-31
Net cash used in operating activities
FY2025; consolidated; currency symbol as printed ($); ISO currency not assigned; year ended 2025-03-31
Financial quality and runway
Financial review

Financial quality and runway

For the year ended March 31, 2026, operating expenses were $15.29 million, operating loss was $15.29 million and net loss was $15.40 million, compared with a $9.48 million net loss in 2025. The filing includes going-concern and internal-control warnings.

Total current assets$1,802,461
Total current assets$1,457,929
Total assets$7,675,191
EvidenceFinancial review 1

Net loss increased from $9.48 million to $15.40 million year over year.

EvidenceFinancial review 2

The auditor’s report includes substantial doubt about going concern, and management identified a material weakness related to accounting resources.

LATEST COMPARISON

MATERIAL CHANGES

The latest material signals and their investor impact are shown below.

Open S-1/A ↗
CHANGE 01Share count increased

Why it mattersCurrent filing reports 32,723,596 shares before the offering and 37,723,596 after it, versus 32,703,469 and 37,703,469 previously.

Evidence · THE OFFERING
CHANGE 02Related ownership and warrant inputs updated

Why it mattersCurrent beneficial ownership figures and underwriter-warrant terminology/amounts differ from the previous excerpt; the current filing states up to 287,500 underwriter-warrant shares and approximately 45% lock-up coverage.

Evidence · Underwriters’ Warrants; Lock-Up Agreements
IPO177 explains the investment effect; the SEC source remains the authoritative record. Page-level locators are shown only when extracted and verified.

Loading filing history…

Risk 1

The company is clinical-stage, has no approved commercial products and has incurred net losses since inception.

Risk 2

The company states that substantial additional capital will be needed even if the offering succeeds.

DocumentS-1/A0001213900-26-077653
Filed2026-07-13SEC EDGAR
Research updated2026-09-14Analysed
Source-bound table inputs53SEC EDGAR
Open filing ↗